date,title,source
Oct-31-18,"Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018",GlobeNewswire
Nov-07-18,Edited Transcript of REPH earnings conference call or presentation 7-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-07-18,"Recro Pharma (REPH) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Recro Pharma: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018,GlobeNewswire
Nov-08-18,Recro Pharma to Participate in Upcoming Investor Conferences,GlobeNewswire
Nov-14-18,Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia,GlobeNewswire
Nov-16-18,"Detailed Research: Economic Perspectives on StarTek, Plantronics, Akoustis Technologies, Genie Energy, Recro Pharma, and BIO-key International  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Nov-20-18,Edited Transcript of REPH earnings conference call or presentation 7-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,Our Take On Recro Pharma Incs (NASDAQ:REPH) CEO Salary,Simply Wall St.
Dec-10-18,Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicams Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology,GlobeNewswire
Dec-21-18,Recro Pharma Amends IV Meloxicam License Agreement with Alkermes,GlobeNewswire
Jan-02-19,Recro Pharma Amends Athyrium Credit Facility,GlobeNewswire
Jan-23-19,5 Domestic Stocks to Gain From Thaw in Trade Talks,Zacks
Jan-30-19,"Could Recro Pharma, Inc.s (NASDAQ:REPH) Investor Composition Influence The Stock Price?",Simply Wall St.
Feb-11-19,Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville,GlobeNewswire
Feb-14-19,5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings,Zacks
Feb-14-19,"Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019",GlobeNewswire
Feb-15-19,What's in the Cards for Bausch Health (BHC) Q4 Earnings?,Zacks
Feb-19-19,Edited Transcript of REPH earnings conference call or presentation 19-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-19-19,Recro Pharma: 4Q Earnings Snapshot,Associated Press
Feb-19-19,Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018,GlobeNewswire
Feb-19-19,"Recro Pharma, Inc. to Host Earnings Call",ACCESSWIRE
Feb-20-19,Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine,GlobeNewswire
Feb-21-19,Edited Transcript of REPH earnings conference call or presentation 19-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-25-19,Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development,GlobeNewswire
Mar-04-19,Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility,GlobeNewswire
Mar-05-19,Options Traders Expect Huge Moves in Recro Pharma (REPH) Stock,Zacks
Mar-12-19,Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting,GlobeNewswire
Mar-22-19,FDA rejects Malvern pharma firm's non-opioid pain killer for a second time,American City Business Journals
Mar-22-19,Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam,GlobeNewswire
Mar-25-19,Why Recro Pharma's stock price plunged more than 34% today,American City Business Journals
Mar-25-19,More Pain For Recro Pharma: FDA Rejects Meloxicam NDA For Second Time,Benzinga
Mar-25-19,Recro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatment,MarketWatch
Mar-25-19,Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors,GlobeNewswire
Mar-26-19,Recro Pharma Falls as FDA Denies Approval to Pain Candidate,Zacks
Apr-03-19,Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance,GlobeNewswire
Apr-04-19,Recro Pharma eliminates 50 jobs following FDA setback,American City Business Journals
Apr-04-19,"The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut",Benzinga
Apr-11-19,Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting,GlobeNewswire
Apr-16-19,Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville,GlobeNewswire
Apr-24-19,"Recro Pharma, Inc. (REPH) Shares March Higher, Can It Continue?",Zacks
Apr-26-19,"Here is What Artko Capital Thinks About Recro Pharma, Inc. (REPH)",Insider Monkey
May-01-19,Recro Pharma (REPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,Zacks
May-06-19,Small Drug Stocks Outlook: Near-Term Prospects Encouraging,Zacks
May-06-19,"Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019",GlobeNewswire
May-08-19,"Recro Pharma, Inc. (REPH): Here are Midwood Capital Managements Thoughts On The Pharmaceutical Company",Insider Monkey
May-08-19,Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates,Zacks
May-10-19,Edited Transcript of REPH earnings conference call or presentation 10-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-10-19,"Recro Pharma (REPH) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-10-19,Recro Pharma: 1Q Earnings Snapshot,Associated Press
May-10-19,Recro Pharma Reports First Quarter 2019 Financial Results,GlobeNewswire
May-14-19,"Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start",Zacks
May-20-19,New Strong Buy Stocks for May 20th,Zacks
May-21-19,Catalent Acquires Gene Therapy Leader Paragon Bioservices,Zacks
May-22-19,Catalyst Pharma (CPRX) Rides on Successful Launch of Firdapse,Zacks
May-24-19,Edited Transcript of REPH earnings conference call or presentation 10-May-19 12:00pm GMT,Thomson Reuters StreetEvents
